Evidence map›Paper›PMID 31317198›Full record

ArticleSingapore medical journal2020

Serum S100β as a predictor of severity and outcomes for mixed subtype acute ischaemic stroke.

Siwat Sakdejayont, Nannapat Pruphetkaew, Pensri Chongphattararot, Paveena Nanphan, Pornchai Sathirapanya

Abstract read
In one paragraph

Article in Singapore medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Siwat SakdejayontDivision of Neurology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Nannapat PruphetkaewEpidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Pensri ChongphattararotDivision of Neurology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Paveena NanphanDivision of Neurology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Pornchai SathirapanyaDivision of Neurology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSerum S100β levels are mostly used for predicting outcomes of large-vessel stroke. Its application to mixed subtypes of acute ischaemic stroke (AIS) has been limited.

methodsPatients with mixed subtypes of AIS who were aged over 18 years and presented within 24 hours of stroke onset were consecutively enrolled. Serum S100β levels at presentation (S100β

results35 patients were eligible for analysis. On univariate analysis, stroke outcomes had a significant association with S100β

conclusionHigh serum S100β is associated with unfavourable outcomes for mixed subtype AIS. Cut-off values of S100β

Indexed as

AdultAgedAged, 80 and overBiomarkersFemaleHumansIschemic StrokeMaleMiddle AgedPrognosisRisk FactorsS100 Calcium Binding Protein beta SubunitStrokeThailandBiomarkersS100B protein, humanS100 Calcium Binding Protein beta Subunitacute ischaemic strokeoutcomeserum S100β

Identifiers

PMID31317198
PMCPMC7905139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.